|
|
|
Price To Earnings Ratio for Major Pharmaceutical Preparations Industry
Valuation Information & Trends 
Price
To Earnings Ratio |
4 Q |
3 Q |
2 Q |
1 Q |
4 Q |
| |
2024 |
2024 |
2024 |
2024 |
2023 |
| PE (TTM) Ratio |
current 59.34 |
42.48 |
45.11 |
46.35 |
36.5 |
| Cumulative Net Income TTM Q / Q Growth |
107.28 % |
-35.75 % |
7.66 % |
-17.05 % |
-19.06 % |
| Stock performance |
to date  -11.6 % |
-3.85 % |
 4.37 % |
1.55 % |
14.88 % |
Note, fourth quarter 2024 Numbers include only companies who have reported fourth quarter 2024 earnings results. Numbers change as more businesses report financial results. See the full List.
|
| Price to earnings ratio Comment |
Price to earnings ratio for the Major Pharmaceutical Preparations Industry
Due to the increase in net income for the trailing twelve month period in fourth quarter 2024, Major Pharmaceutical Preparations Industry's current Price to earnings ratio is at 42.38.
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
